Literature DB >> 11552072

DNA analysis for the Dombrock polymorphism.

M Rios1, K Hue-Roye, A H Lee, J T Chiofolo, J L Miller, M E Reid.   

Abstract

BACKGROUND: RBC typing for Do(a) and Do(b) is notoriously difficult, and inaccurate typing can predispose patients to hemolytic transfusion reactions. The DO1/DO2 polymorphism is associated with three nucleotide changes: 378 C>T, 624 T>C and 793 A>G. While the 378 C>T- and 624 T>C-containing codons are silent mutations, the 793 A>G polymorphism in codon 265 encodes asparagine for Do(a) and aspartic acid for Do(b). STUDY DESIGN AND METHODS: Described here are two PCR-RFLP assays, one using the Mnl I site associated with 624C (DO2) and the other altering two nucleotides within the sense primer, which allows recognition of 793G by the Eam 1105 I.
RESULTS: The assays have been performed on over 100 samples for which the RBC typing of one or both antigens was known. Eight samples had been historically mistyped by hemagglutination.
CONCLUSION: This RFLP assay provides a practical method for typing donor blood for Dombrock alleles.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11552072     DOI: 10.1046/j.1537-2995.2001.41091143.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  2 in total

1.  A PCR-based strategy for Dombrock screening in Brazilian blood donors reveals a novel allele: the DO* A-WL.

Authors:  Wilson Baleotti; Rodrigo Buzinaro Suzuki; Milena Polotto; Marcelo Ortega Ruiz; Antonio Fabron; Lilian Castilho
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

2.  Genotyping of Dombrock and Lutheran blood group systems in blood donors from the southwestern region of the state of Paraná, Southern Brazil.

Authors:  Ieda Bernadete Volkweis Langer; Jeane Eliete Laguila Visentainer; Joana Maira Valentini Zacarias; Katia Teixeira de Meiroz Grilo; Paulo Roberto Hatschbach; Rosane Scotti Zimmermann; Ana Maria Sell
Journal:  Hematol Transfus Cell Ther       Date:  2018-07-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.